All PlansPrior AuthMedium impact
Newsletter Vol. 10, No. 69
New Jersey Medicaid·NJ · Endocrinology, Pediatrics, Family Medicine +1 more·Provider Notice
We identified it
Jun 20, 2026
Summary
The policy introduces revised Prior Drug Utilization Review (PDUR) standards for Somatropin, which is a growth hormone medication. This change will likely affect the prior authorization requirements, documentation standards, or coverage criteria for prescribing Somatropin.
Action Required
Review the full Newsletter Vol. 10, No. 69 document at the provided URL to understand specific PDUR requirements for Somatropin prescriptions. Update prior authorization workflows and documentation requirements as specified in the revised standards. Ensure providers are aware of any new criteria for Somatropin coverage.